“The lower rating reflects our opinion of OGHS’ vulnerable enterprise profile, highlighted by what we consider low market share due to substantial outmigration for tertiary services to nearby competitors and declining admissions through fiscal 2016,” said S&P analyst Charlene Butterfield. “We believe our expectation of further improvement in the financial profile provides stability at the current rating.”
The outlook is stable.
More articles on healthcare finance:
Bipartisan group of senators unveil proposed Medicare reforms
Brigham and Women’s invests $4.5M in local organizations
Sacred Heart picks dbtech’s report distribution, analysis and archive solution
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit